Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovations in Europe, particularly through links with many institutes. research and prestigious hospitals.

Kurma Partners

Agoranov is a public Science & Tech incubator that provides mentorship, office space, funding, and consultancy services to startups. The company is based in Paris. Agoranov has supported more than 380 startups that have already created more than 7,000 direct jobs and raised €700 million from private funds. Among them Criteo (NASDAQ: CRTO), Anevia, Biophytis, Gensight and Pixium listed on Alternext, or Aldebaran, Dataiku, Doctolib, Point Vision and Ynsect. Agoranov, founded by the Universities Pierre and Marie Curie and Paris-Dauphine, Ecole Normale Supérieure, ParisTech, and INRIA, is supported by the Ministry of Research and Higher Education, the Ile de France Region, the City of Paris and the European Social Fund. Agoranov provides its 60 incubated with personalized support, a state-of-the-art acceleration program, quality accommodation in the center of Paris and a rich community of several hundred entrepreneurs.

AGORANOV

Sofinnova Partners is a venture capital firm that invests in the life sciences sector, from seed to later-stage. The firm manages over €2 billion of assets dedicated to life science investing and actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact its collective future. It invests in start-ups, early-stage companies, corporate spin-offs, and occasionally turnaround situations with a focus on Life Sciences (Biopharmaceuticals / Biotech, Medical Devices, Industrial Biotechnology). Sofinnova Partners proactively sources deals, takes a lead role, is most often the first institutional investor in Round A financings, and leads its portfolio companies until exit. They sit on the boards of their portfolio companies and play an active role from the formation phase alongside entrepreneurs. It was headquartered in Paris, Ile-de-France in 1972.

Sofinnova Partners

Casdin Capital is a fundamental research investment firm focused on the life sciences and healthcare industry. It manages a long-short equity fund and makes investments in early-stage to late-stage private investments.  Casdin was launched in 2012 by founder and CIO Eli Casdin and as of October 2020 has approximately $2.2 billion in assets under management.

Casdin Capital

Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.

Bpifrance

Genoa Ventures invests in early-stage life sciences technology companies. They fund entrepreneurs and companies looking to change the way science gets done with new tools and technologies. Sector focus areas include research tools, molecular diagnostics, synthetic biology, and industrial biology. Genoa Ventures was founded in 2014 by Jenny Rooke and is based in San Francisco, California, United States.

Genoa Ventures

Alexandria Venture Investments is a venture capital firm that develops work in real estate technology, and healthcare sectors. The company's strategic venture capital platform is Alexandria Venture Investments. Since its inception in 1996, the company has invested in disruptive life science, agrifood tech, and technology companies that are developing transformative new modalities and platforms to meaningfully improve human health.

Alexandria Venture Investments

Meiogenix

Meiogenix is a biotech company developing breeding technologies to unlock the unexplored genetic diversity of organisms. Meiogenix expands the natural biodiversity and helps developing new products to address global food and industrial challenges.

<div><p>Meiogenix engages in chromosome editing to develop innovative products. It aims to expand the biodiversity that can be used by farmers to address global climate, sustainability, and food challenges by unlocking the natural genetic diversity of crops. Meiogenix’s technology enables the targeting of homologous recombination in plant genomes, allowing the re-assembly of traits during the breeding process. Meanwhile, Meiogenix product development, which is based on the natural process of recombination, reduces lengthy breeding cycles and allows the development of entirely new complex traits or natural biodiversity. Headquartered in France, Meiogenix is privately held and has operations in the US.</p></div>

Enhancing seed and crop traits via biotechnology

Crop Biotech

Meiogenix Names Ricardo Garcia de Alba as New CEO to Drive Global Agricultural Innovation

Bayer

Announced a collaboration to advance agricultural research and development by accelerating the development of Meiogenix’s proprietary technologies related to plant breeding and genome editing applications

Companies that develop a platform to insert, edit, or delete the DNA of a plant itself using approaches such as CRISPR-Cas 9, TALENs, and Zinc Fingers. These approaches help develop plant genes or seeds with traits such as disease-resistant, enhanced-performance, or improve yield.

<div>
  <p>
    Meiogenix engages in chromosome editing to develop innovative products. It aims to expand the biodiversity that can be used by farmers to address global climate, sustainability, and food challenges by unlocking the natural genetic diversity of crops. Meiogenix’s technology enables the targeting of homologous recombination in plant genomes, allowing the re-assembly of traits during the breeding process. Meanwhile, Meiogenix product development, which is based on the natural process of recombination, reduces lengthy breeding cycles and allows the development of entirely new complex traits or natural biodiversity. Headquartered in France, Meiogenix is privately held and has operations in the US.
  </p>
</div>


<p><span>Lone Star Industrial Materials is a cultivation company that manufactures raw hemp materials. Its product portfolio consists of bast fiber, refined cellulose, and hemp hurd, seeds, hearts, fines and oil. Additionally, it offers retail products such as HempSorb, animal bedding, and hemp control socks. Hemp requires less land, improves nutritional health, is environmentally friendly, helps soil regeneration, grows in various climates, absorbs a great deal of CO2, is a rotational crop and reduces waste. Hemp is used in construction, insulation, bioplastics, and as hemp wood. The privately held company has developed an end-to-end supply chain from seed genetics to delivery.</span></p>

Lone Star Industrial Materials

<p><span>PLANTeDIT operates in the plant genome editing field to produce improved crop species through transformation technology and a CRISPR/Cas9 delivery system. It produces regulatory-free, consumer-oriented, DNA-free and sustainable genome edited crops and biopharmaceuticals. The company’s offering includes non-transgenic high oleic soya, which is produced by mutating the FAD2 gene, which eventually increases the oleic oil content in the soya bean. This product was developed through a collaboration between PLANTeDIT and ToolGen. The organization has also collaborated with RebelBio, University College Cork and IAPB. Headquartered in Cork, Ireland, PLANTeDIT is privately held.</span></p>

PLANTEDIT

<div>
  <p>
    Amforo is a biotech company that focuses on developing foods that are high in protein by enhancing the nutritional density of food and feed crops through the platform of technologies it has built. The company offers a family of feed and food crops, including primary ingredients for suppliers of plant-based meat and dairy alternatives. In addition, it is focused on developing a low-cost, plant-based source of protein for farmed seafood. Moreover, Amforo is pursuing approaches to enhance the nutritional profile of crops as well as their protein content, which entails optimizing amino acid profiles, modifying carbohydrates, and enhancing micronutrients.
  </p>
</div>


Amfora

<p><span>BioHeuris provides weed management solutions by combining synthetic biology and gene editing to develop herbicide resistant crops. Its offering includes Heurik, a technology platform that integrates rational design and directed evolution to identify mutations that confer herbicide tolerance, while Swap is the platform that introduces these mutations in crops using gene editing. The company cultivates soybeans, sorghum, rice, cotton, and alfalfa. It has partnered with Santa Rosa Semillas, Adecoagro, Gensus, GDM, Aceleradora Litoral, Tobin, Rotam, Asociación de Cooperativas Argentinas, Benson Hill, and Plant Science Center. Headquartered in Rosario, Argentina, BioHeuris is privately held with an office in the US.</span></p>

BioHeuris

<div>
  <p>
    Tropic Biosciences is a privately held developer of high-performing commercial varieties of tropical crops that promote cultivation efficiencies, improve sustainable environmental practices and enhance consumer health through its use of cutting-edge genetic editing technologies. Its GEiGS Technology combines gene editing and RNAi in a single platform that enables critical disease resistance and quality improvement traits. The technology caters to the banana production, row crops, livestock, and poultry industries. The company’s partners include Temasek, Agronomics, Polaris Founders Capital, and Excellence Through Stewardship. Headquartered in the UK, Tropical Biosciences has been featured in The Telegraph, Nature, Fast Company, and the Financial Times. 
  </p>
</div>


Tropic Biosciences

Companies that develop or use biological, physical and chemical agents and techniques to provide protection and improve the quality of a seed. This includes the sale of seed coating, or seed enhancement products as methods to treat seeds.

Companies that redesign large clusters of genes and gene parts rather than modifying or engineering a single gene for improving the traits of a plant.

Companies that utilize genetic engineering tools and technologies to use existing and naturally present gene variants in a plant and the natural process of breeding such as inbreeding, and linebreeding to develop better traits for plants.

Companies that use transgenesis processes like tissue culturing to develop transgenic plants or seeds by inserting new genes into them from other plants or in certain instances other organisms like bacteria or even animals.

Companies that offer techniques such as epigenetics, RNA interference (RNAi) to temporarily block a specific gene that would trigger unwanted effect such as a disease on a plant.

Biotech solutions to produce crops that are sustainable and offer better traits

Offers customization of genes and traits as required by farmers

Uses AI/machine learning to facilitate their platform/biotech processes like gene editing

Meiogenix

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless